Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review.

PubWeight™: 2.95‹?› | Rank: Top 1%

🔗 View Article (PMC 1479850)

Published in BMJ on March 24, 2006

Authors

Penny Whiting1, Roger Harbord, Caroline Main, Jonathan J Deeks, Graziella Filippini, Matthias Egger, Jonathan A C Sterne

Author Affiliations

1: MRC Health Services Research Collaboration, Department of Social Medicine, Bristol BS8 2PR. penny.whiting@bristol.ac.uk

Articles citing this

Systematic reviews of diagnostic test accuracy. Ann Intern Med (2008) 4.84

Medical academia is failing patients and clinicians. BMJ (2006) 1.59

The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS). PLoS One (2010) 1.32

IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome. PLoS One (2009) 1.25

PCR using blood for diagnosis of invasive pneumococcal disease: systematic review and meta-analysis. J Clin Microbiol (2009) 0.99

Graphical presentation of diagnostic information. BMC Med Res Methodol (2008) 0.94

Brain metabolite proton T2 mapping at 3.0 T in relapsing-remitting multiple sclerosis. Radiology (2010) 0.86

Role of MRI in diagnosing multiple sclerosis: magnetic resonance imaging is valuable. BMJ (2006) 0.79

The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study. Neurology (2016) 0.78

Functional brain imaging: an evidence-based analysis. Ont Health Technol Assess Ser (2006) 0.78

Glatiramer acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system? Int J Mol Sci (2012) 0.78

Role of MRI in diagnosing multiple sclerosis: early diagnosis using MRI and early treatment delays disease conversion. BMJ (2006) 0.75

Review: magnetic resonance imaging alone is of limited usefulness in diagnosing multiple sclerosis. Evid Based Med (2006) 0.75

Application of Texture Analysis in Diagnosis of Multiple Sclerosis by Magnetic Resonance Imaging. Glob J Health Sci (2015) 0.75

Magnetic resonance imaging in multiple sclerosis--patients' experiences, information interests and responses to an education programme. PLoS One (2014) 0.75

Evidence-based neuroradiology: a necessity. Neuroradiology (2007) 0.75

Review: magnetic resonance imaging alone is of limited usefulness in diagnosing multiple sclerosis. ACP J Club (2006) 0.75

Articles cited by this

New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol (1983) 26.67

Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36

Diagnostic tests 4: likelihood ratios. BMJ (2004) 7.33

Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med (2004) 6.87

Controlling the risk of spurious findings from meta-regression. Stat Med (2004) 6.80

Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess (2004) 5.31

A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med (2001) 4.92

Diagnosis and classification of multiple sclerosis. Br Med Bull (1977) 4.68

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain (1997) 3.87

A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med (2002) 3.74

The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2003) 3.21

High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol (2003) 3.13

New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology (2003) 2.04

Test research versus diagnostic research. Clin Chem (2004) 1.72

New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes. Ann Neurol (2003) 1.66

Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol (2002) 1.57

Empirical Bayes estimates generated in a hierarchical summary ROC analysis agreed closely with those of a full Bayesian analysis. J Clin Epidemiol (2004) 1.52

The early risk of multiple sclerosis after optic neuritis. J Neurol Neurosurg Psychiatry (1988) 1.26

Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Ann Neurol (2004) 1.25

The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis. Ann Neurol (1991) 1.20

The value of diagnostic information to patients with suspected multiple sclerosis. Rochester-Toronto MRI Study Group. Arch Neurol (1994) 1.10

The journey to multiple sclerosis: a qualitative study. J Neurosci Nurs (1999) 1.08

Key issues in the diagnosis and treatment of multiple sclerosis. An overview. Neurology (2002) 1.07

Delivering the diagnosis of MS--results of a survey among patients and neurologists. Acta Neurol Scand (2003) 1.03

Effect of diagnostic testing for multiple sclerosis on patient health perceptions. Rochester-Toronto MRI Study Group. Arch Neurol (1994) 0.96

The accuracy of magnetic resonance imaging in patients with suspected multiple sclerosis. The Rochester-Toronto Magnetic Resonance Imaging Study Group. JAMA (1993) 0.95

Diagnostic criteria for multiple sclerosis: an historical review. Clin Neurol Neurosurg (2004) 0.91

Diagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria. J Neurol Neurosurg Psychiatry (1995) 0.88

Articles by these authors

Measuring inconsistency in meta-analyses. BMJ (2003) 128.20

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet (2006) 31.79

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet (2008) 20.62

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (2007) 20.57

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet (2002) 16.56

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med (2011) 15.02

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (2007) 14.52

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol (2008) 14.36

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet (2009) 14.01

Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS (2009) 11.62

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (2008) 11.08

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med (2007) 10.43

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet (2004) 9.88

Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med (2008) 9.39

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med (2007) 8.77

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet (2004) 8.77

Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ (2008) 8.70

Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One (2009) 8.58

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med (2007) 8.46

Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet (2005) 7.89

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med (2007) 7.87

CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol (2010) 7.04

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet (2009) 6.92

Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet (2011) 6.91

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ (2011) 6.89

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ (2003) 6.61

Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet (2005) 6.60

Evidence of methodological bias in hospital standardised mortality ratios: retrospective database study of English hospitals. BMJ (2009) 6.08

Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet (2010) 6.02

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS (2010) 5.85

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology (2007) 5.77

A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med (2006) 5.43

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ (2007) 5.38

When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study. Ann Intern Med (2011) 5.35

Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health (2008) 5.32

Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis (2005) 5.20

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology (2007) 5.12

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet (2006) 5.00

Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev (2009) 4.86

Systematic reviews of diagnostic test accuracy. Ann Intern Med (2008) 4.84

Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet (2005) 4.82

Home visits to prevent nursing home admission and functional decline in elderly people: systematic review and meta-regression analysis. JAMA (2002) 4.75

Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS (2010) 4.68

Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis (2010) 4.56

Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med (2007) 4.56

Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ (2009) 4.38

Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health (Larchmt) (2008) 4.38

Interpretation of random effects meta-analyses. BMJ (2011) 4.32

Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS (2007) 4.31

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med (2007) 4.29

Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: lighten Up randomised controlled trial. BMJ (2011) 4.25

Rapid diagnostic tests for diagnosing uncomplicated P. falciparum malaria in endemic countries. Cochrane Database Syst Rev (2011) 4.11

What is newsworthy? Longitudinal study of the reporting of medical research in two British newspapers. BMJ (2002) 4.05

Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med (2006) 3.98

Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet (2004) 3.96

Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. J Clin Epidemiol (2004) 3.93

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol (2009) 3.91

Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings. Bull World Health Organ (2008) 3.85

Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol (2002) 3.79

Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med (2007) 3.71

Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med (2012) 3.63

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med (2005) 3.60

Quality of reporting of randomized trials as a measure of methodologic quality. JAMA (2002) 3.60

NHS waiting lists and evidence of national or local failure: analysis of health service data. BMJ (2003) 3.60

Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ (2002) 3.57

CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg (2011) 3.57

Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared. PLoS Med (2008) 3.56

Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial. BMJ (2006) 3.48

Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev (2011) 3.44

Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health (2012) 3.43

Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med (2009) 3.42

CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med (2003) 3.41

The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. Am J Epidemiol (2007) 3.40

Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. AIDS (2008) 3.31

Secular trends in mortality by stroke subtype in the 20th century: a retrospective analysis. Lancet (2002) 3.29

Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort. Antivir Ther (2007) 3.27

A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics (2006) 3.23

Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial. Arthritis Rheum (2007) 3.22

Schizophrenia and suicide: systematic review of risk factors. Br J Psychiatry (2005) 3.21

Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts. Int J Epidemiol (2005) 3.19

Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research. Stat Med (2002) 3.16

Meta-analysis: accuracy of rapid tests for malaria in travelers returning from endemic areas. Ann Intern Med (2005) 3.08

Missed opportunities to prevent mother-to-child-transmission: systematic review and meta-analysis. AIDS (2012) 3.05

Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med (2013) 3.03

Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy. Trop Med Int Health (2009) 2.99